CoChat

HIF activation identifies early lesions in VHL kidneys

Open access

The DOI matches its Crossref record, with a small difference in title or year; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Mutations in the von Hippel-Lindau (VHL) gene are associated with hereditary and sporadic clear cell renal carcinoma. VHL acts in a ubiquitin ligase complex regulating hypoxia-inducible factor-1 (HIF-1), but the link between this function and cancer development is unclear. Here we show that in the kidneys of patients with VHL disease, HIF activation is an early event occurring in morphologically normal single cells within the renal tubules. In comparison, dysplastic lesions, cystic lesions, and tumors showed evidence of additional mechanisms that amplify HIF activation. Detection of cells with constitutive HIF activation identified a large number of previously unrecognized foci of VHL inactivation. In proximal tubules these were almost entirely unicellular, whereas multicellular foci were almost exclusively seen in the distal nephron.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(02)00071-5

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Research works printed but not linked: 2

  1. de Paulsen, 2001, Role of transforming growth factor-α in von Hippel-Lindau (VHL)(−/−) clear cell renal carcinoma cell proliferation, Proc. Natl. Acad. Sci. USA, 98, 1387
  2. Haase, 2001, Consequences of conditional inactivation of the VHL tumor suppressor in the murine renal cortex, JASN, 12, A2870

Cited by

See all 541

Metadata

Authors
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., & Maxwell, P. H.
Affiliations
  • Centre for Human Genetics (GB)
  • Cancer Research UK (GB)
  • John Radcliffe Hospital (GB)
  • University of Birmingham (GB)
Corresponding author
Maxwell, Patrick H
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2002-06
Volume
1
Issue
5
Pages
459-468
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2024064023
Cited by
483
References
51
Citations by year
2026: 10 · 2025: 8 · 2024: 21 · 2023: 11 · 2022: 19 · 2021: 18 · 2020: 17 · 2019: 14 · 2018: 26 · 2017: 18 · 2016: 14 · 2015: 19 · 2014: 18 · 2013: 34 · 2012: 23
FWCI
8.07
Type
journal article
Language
en
Open access
Licence
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
Keywords
von Hippel-Lindau gene, von Hippel-Lindau disease, HIF-1, HIF activation, clear cell renal cell carcinoma, renal tubules, proximal tubule, distal nephron, renal dysplasia, renal cysts, ubiquitin ligase
MeSH terms
Carbonic Anhydrase IX, Adult, Antigens, Neoplasm, Carbonic Anhydrases, Carcinoma, Renal Cell, DNA-Binding Proteins, von Hippel-Lindau Disease, Humans, Immunoenzyme Techniques, Kidney Neoplasms, Middle Aged, Monosaccharide Transport Proteins, Neoplasm Proteins, Nephrectomy, Nephrons, Nuclear Proteins, Transcription Factors, RNA Probes, Antigens, CD, Genes, Tumor Suppressor, Apoptosis, In Situ Hybridization, Adenocarcinoma, Clear Cell, In Situ Nick-End Labeling, Glucose Transporter Type 1, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF activation identifies early lesions in VHL kidneys. https://app.cochat.ai/papers/10.1016/s1535-6108(02)00071-5
The paper
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., & Maxwell, P. H. (2002). HIF activation identifies early lesions in VHL kidneys. Cancer Cell. https://doi.org/10.1016/s1535-6108(02)00071-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.